Background: During human immunodeficiency virus (HIV) disease, chronic immune activation leads to T-cell exhaustion. PD-1 identifies "exhausted" CD8 T cells with impaired HIV-specific effector functions, but its role on CD4 T cells and in HIV-infected children is poorly understood. Methods: In a Kenyan cohort of vertically HIV-infected children, we measured PD-1+ CD4 T-cell frequencies and phenotype by flow cytometry and their correlation with HIV disease progression and immune activation. Second, in vitro CD4 T-cell proliferative and cytokine responses to HIV-specific and -nonspecific stimuli were assessed with and without PD-1 blockade. Results: HIV-infected children have increased frequencies of PD-1+ memory CD4 T cells that fail to normalize with antiretroviral treatment. These cells are comprised of central and effector memory subsets and correlate with HIV disease progression, measured by viral load, CD4 percentage, CD4:CD8 T-cell ratio, and immune activation. Last, PD-1+ CD4 T cells predict impaired proliferative potential yet preferentially secrete the Th1 and Th17 cytokines interferon-γ and interleukin 17A, and are unresponsive to in vitro PD-1 blockade. Conclusions: This study highlights differences in PD-1+ CD4 T-cell memory phenotype and response to blockade between HIV-infected children and adults, with implications for potential immune checkpoint therapies.
Background: During human immunodeficiency virus (HIV) disease, chronic immune activation leads to T-cell exhaustion. PD-1 identifies "exhausted" CD8 T cells with impaired HIV-specific effector functions, but its role on CD4 T cells and in HIV-infectedchildren is poorly understood. Methods: In a Kenyan cohort of vertically HIV-infectedchildren, we measured PD-1+ CD4 T-cell frequencies and phenotype by flow cytometry and their correlation with HIV disease progression and immune activation. Second, in vitro CD4 T-cell proliferative and cytokine responses to HIV-specific and -nonspecific stimuli were assessed with and without PD-1 blockade. Results:HIV-infectedchildren have increased frequencies of PD-1+ memory CD4 T cells that fail to normalize with antiretroviral treatment. These cells are comprised of central and effector memory subsets and correlate with HIV disease progression, measured by viral load, CD4 percentage, CD4:CD8 T-cell ratio, and immune activation. Last, PD-1+ CD4 T cells predict impaired proliferative potential yet preferentially secrete the Th1 and Th17 cytokines interferon-γ and interleukin 17A, and are unresponsive to in vitro PD-1 blockade. Conclusions: This study highlights differences in PD-1+ CD4 T-cell memory phenotype and response to blockade between HIV-infectedchildren and adults, with implications for potential immune checkpoint therapies.
Authors: Andrew Prendergast; Maria O'Callaghan; Esse Menson; Djamel Hamadache; Sam Walters; Nigel Klein; Philip Goulder Journal: AIDS Res Hum Retroviruses Date: 2011-09-07 Impact factor: 2.205
Authors: Fusheng Li; Uma Malhotra; Peter B Gilbert; Natalie R Hawkins; Ann C Duerr; Juliana M McElrath; Lawrence Corey; Steven G Self Journal: Vaccine Date: 2006-06-27 Impact factor: 3.641
Authors: Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann Journal: J Virol Date: 2013-12-18 Impact factor: 5.103
Authors: Jaikumar Duraiswamy; Chris C Ibegbu; David Masopust; Joseph D Miller; Koichi Araki; Gregory H Doho; Pramila Tata; Satish Gupta; Michael J Zilliox; Helder I Nakaya; Bali Pulendran; W Nicholas Haining; Gordon J Freeman; Rafi Ahmed Journal: J Immunol Date: 2011-03-07 Impact factor: 5.422
Authors: Cynthia L Gay; Ronald J Bosch; Justin Ritz; Jason M Hataye; Evgenia Aga; Randall L Tressler; Stephen W Mason; Carey K Hwang; Dennis M Grasela; Neelanjana Ray; Josh C Cyktor; John M Coffin; Edward P Acosta; Richard A Koup; John W Mellors; Joseph J Eron Journal: J Infect Dis Date: 2017-06-01 Impact factor: 5.226
Authors: Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao Journal: AIDS Res Hum Retroviruses Date: 2009-01 Impact factor: 2.205
Authors: Daniel E Kaufmann; Daniel G Kavanagh; Florencia Pereyra; John J Zaunders; Elizabeth W Mackey; Toshiyuki Miura; Sarah Palmer; Mark Brockman; Almas Rathod; Alicja Piechocka-Trocha; Brett Baker; Baogong Zhu; Sylvie Le Gall; Michael T Waring; Ryan Ahern; Kristin Moss; Anthony D Kelleher; John M Coffin; Gordon J Freeman; Eric S Rosenberg; Bruce D Walker Journal: Nat Immunol Date: 2007-09-30 Impact factor: 25.606
Authors: Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly Journal: Nat Med Date: 2009-06-21 Impact factor: 53.440
Authors: Greg S Gojanovich; Cecilia M Shikuma; Cris Milne; Daniel E Libutti; Dominic C Chow; Mariana Gerschenson Journal: AIDS Res Hum Retroviruses Date: 2019-09-17 Impact factor: 2.205
Authors: Alexandra M Miggelbrink; Joshua D Jackson; Selena J Lorrey; Ethan S Srinivasan; Jessica Waibl-Polania; Daniel S Wilkinson; Peter E Fecci Journal: Clin Cancer Res Date: 2021-06-14 Impact factor: 12.531
Authors: Cheryl L Day; Deborah A Abrahams; Rubina Bunjun; Lynnett Stone; Marwou de Kock; Gerhard Walzl; Robert J Wilkinson; Wendy A Burgers; Willem A Hanekom Journal: Front Immunol Date: 2018-08-31 Impact factor: 7.561
Authors: Mohamed Tarek M Shata; Enass A Abdel-Hameed; Susan D Rouster; Li Yu; Meina Liang; Esther Song; Mark T Esser; Norah Shire; Kenneth E Sherman Journal: Pathog Immun Date: 2019-02-13
Authors: Annalisa Dalzini; Maria Raffaella Petrara; Giovanni Ballin; Marisa Zanchetta; Carlo Giaquinto; Anita De Rossi Journal: J Immunol Res Date: 2020-05-16 Impact factor: 4.818
Authors: Svetlana Bornschlegl; Michael P Gustafson; Danae A Delivanis; Mabel Ryder; Minetta C Liu; George Vasmatzis; Chris L Hallemeier; Sean S Park; Lewis R Roberts; Ian F Parney; Diane F Jelinek; Allan B Dietz Journal: Clin Transl Immunology Date: 2021-04-29